Literature DB >> 17947474

p53 mutations in deep tissues are more strongly associated with recurrence than mutation-positive mucosal margins.

Xiaohong Huang1, Stelios Pateromichelakis, Allison Hills, Martyn Sherriff, Andrew Lyons, John Langdon, Edward Odell, Peter Morgan, John Harrison, Max Partridge.   

Abstract

PURPOSE: Application of ultrasensitive diagnostics has shown that small numbers of p53 mutation-positive cells may signify the presence of residual tumor in histologically normal tissues after resection of squamous cell carcinomas arising in the head and neck area. To date, most studies in this area have focused on analysis of tissues at the mucosal aspect of the resection and highlighted the importance of molecular changes in the field with respect to the risk of recurrence. EXPERIMENTAL
DESIGN: In the present investigation, we analyzed normal tissues from mucosal and deep surgical margins, referred to as "molecular margins," for the presence of the signature p53 mutation identified for each tumor.
RESULTS: The p53 mutation status of these carcinomas did not correlate with clinical or histopathologic variables, but these mutations provided an excellent target for ultrasensitive analysis of margin status. We found that 11 of 16 (68%) of cases with histologically tumor-free (including 9 without dysplasia), but with p53 mutation-positive molecular margins, developed recurrence. The probability of developing local recurrence was significantly higher for the group with p53 mutation-positive margins when compared with the group with clear margins (P = 0.048) and more strongly associated with p53 mutation-positive deep molecular margins than mutation-positive mucosal molecular margins or positivity at both sites (P = 0.009).
CONCLUSIONS: This shows that although persistent mucosal fields may contribute to recurrence, clonal p53 mutations in deep tissues are an important cause of treatment failure, and molecular margins from both sites should be analyzed in future prospective series.

Entities:  

Mesh:

Year:  2007        PMID: 17947474     DOI: 10.1158/1078-0432.CCR-07-1369

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  9 in total

Review 1.  Molecular margins in head and neck cancer: Current techniques and future directions.

Authors:  Katelyn O Stepan; Michael M Li; Stephen Y Kang; Sidharth V Puram
Journal:  Oral Oncol       Date:  2020-07-20       Impact factor: 5.337

2.  The Ligamp TP53 Assay for Detection of Minimal Residual Disease in Head and Neck Squamous Cell Carcinoma Surgical Margins.

Authors:  M Luana Poeta; Judith Manola; David Goldenberg; Arlene Forastiere; Joseph A Califano; John A Ridge; Jarrard Goodwin; Daniel Kenady; John Saunders; William Westra; David Sidransky; Wayne M Koch
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

3.  Tissue imprint for molecular mapping of deep surgical margins in patients with head and neck squamous cell carcinoma.

Authors:  Jong-Lyel Roh; William H Westra; Joseph A Califano; David Sidransky; Wayne M Koch
Journal:  Head Neck       Date:  2012-01-03       Impact factor: 3.147

4.  Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.

Authors:  Masamichi Hayashi; Gaosong Wu; Jong-Lyel Roh; Xiaofei Chang; Xiufeng Li; Julie Ahn; Marla Goldsmith; Zubair Khan; Justin Bishop; Zhe Zhang; Xian Chong Zhou; Jeremy Richmon; Nishant Agrawal; Wayne M Koch
Journal:  Cancer       Date:  2015-03-13       Impact factor: 6.860

5.  p53: a molecular marker for the detection of cancer.

Authors:  Mark T Boyd; Nikolina Vlatkovic
Journal:  Expert Opin Med Diagn       Date:  2008-09

6.  Paired box 5 methylation detection by droplet digital PCR for ultra-sensitive deep surgical margins analysis of head and neck squamous cell carcinoma.

Authors:  Masamichi Hayashi; Rafael Guerrero-Preston; David Sidransky; Wayne M Koch
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-24

7.  p53-positive expression in dysplastic surgical margins is a predictor of tumor recurrence in patients with early oral squamous cell carcinoma.

Authors:  Xi-Hu Yang; Liang Ding; Yong Fu; Sheng Chen; Lei Zhang; Xiao-Xin Zhang; Xiao-Feng Huang; Zhan-Yi Lu; Yan-Hong Ni; Qin-Gang Hu
Journal:  Cancer Manag Res       Date:  2019-02-13       Impact factor: 3.989

8.  The antiangiogenic agent ZD4190 prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissues.

Authors:  K Gaballah; R Oakley; A Hills; A Ryan; M Partridge
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

9.  The utility of molecular diagnostics to predict recurrence of head and neck carcinoma.

Authors:  C Pena Murillo; X Huang; A Hills; M McGurk; A Lyons; J-P Jeannon; E Odell; A Brown; K Lavery; W Barrett; M Sherriff; R Brakenhoff; M Partridge
Journal:  Br J Cancer       Date:  2012-08-23       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.